McKesson announced a cardiology solution called Qualitative Intelligence and Communication System (QICS). QICS for cardiology helps organizations automate and manage cardiology workflows to promote efficiency and effectiveness. The solution offers integrated workflows and results communications management within the cardiovascular information system (CVIS).

Corindus CorPath Robotic Navigation Telemedicine Telecardiology Cath Lab

For patients living in rural areas, life-saving procedures such as an angioplasty may only be available at a facility more than 200 miles away. To bridge this distance, Corindus Vascular Robotics is partnering with Sanford Health and The Leona M. and Harry B. Helmsley Charitable Trust to launch a feasibility study for a remote robotic systems cath lab telecardiology program. 

Countries across the globe are struggling to combat issues such as escalating healthcare costs, poor or inconsistent quality of healthcare, rapid expansion in healthcare insurance and changing healthcare reform mandates. Growing consumerism, globalization, changing demographics and lifestyles, and growing incidences of diseases that are expensive to treat further exacerbate these. Resolving these issues is a daunting task faced by healthcare stakeholders, highlighting the need for proactive, collaborative and systemic models. Several initiatives and healthcare reforms have been developed in order to support the adoption and implementation of clinical decision support software (CDSS) solutions.

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray

Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in X-ray medical examinations. FlowSens received CE marking in the first quarter of 2014. It will initially be marketed in Europe (first in Belgium, France, Germany and Switzerland), then gradually in other regions of the world.

Marty Greenfield lives with crushing pain every day due to angina. He has suffered a heart attack, and a coronary bypass procedure and angioplasty have provided little relief. His doctor referred him to University of California, Los Angeles to be considered for a heart transplant.

After a heart attack, there is often permanent damage to a portion of the heart. This happens, in part, because cardiac muscle cells are terminally differentiated and cannot proliferate after blood flow is blocked off to the heart. This partial healing can be attributed to heart disease being one of the leading causes of death. What if the cells could be stimulated to divide and the heart could be induced to repair itself? This was the question posed by George Washington University researcher Scott Shapiro, M.D., Ph.D., and his co-authors. They found cardiac regeneration may be a possibility with gene therapy.

ImaCor Inc., the developer of hemodynamic transesophageal echocardiography (hTEE) technology, announced four academic hTEE presentations. Physicians are publicly recognizing hTEE as a tool for managing complex ICU patients. 

Without administering a simple blood test in the first few days after surgery, 85 percent of the heart attacks or injuries patients suffer could be missed, according to a study in the March issue of Anesthesiology. Globally, more than 8 million adults have heart attacks or injuries after surgery every year, and 10 percent of those patients die within 30 days.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now